Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Manager
Telephone: 412-623-4701 or 412-586-9773

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

UPMC Media Relations

New Radiotherapy Strategy Improves Survival For Lung Cancer Patients According To University Of Pittsburgh-Led Study

PITTSBURGH, June 1, 2003 Study results presented at the 39th annual meeting for the American Society of Clinical Oncology (ASCO) by Chandra P. Belani, M.D., professor of medicine, University of Pittsburgh and co-director, Lung Cancer Program, University of Pittsburgh Cancer Institute (UPCI), demonstrate that a new therapeutic radiation strategy for non-small cell lung cancer (NSCLC) the most common form of the disease leads to improved survival for lung cancer patients with locally advanced disease.

In the study, hyperfractionated accelerated radiotherapy (HART) was compared to standard thoracic radiotherapy following chemotherapy. HART is a strategy in which radiation is administered frequently over a shorter period of time for two and a half weeks compared to seven weeks.

The phase III multi-site study compared HART to standard radiation therapy in 119 patients with unresectable stage III NSCLC. The patients were randomized into the two groups following two cycles of chemotherapy. Results indicated a median survival of 21 months for patients who received chemotherapy followed by HART, compared to a median survival of 12 months for patients who received chemotherapy followed by standard radiation therapy. One, two and three-year survival rates were 60 percent, 37 percent and 23 percent respectively in the HART group compared to one, two and three-year survival rates of 52 percent, 28 percent and 15 percent in the standard radiation therapy group.

We found that chemotherapy followed by HART was an effective treatment strategy that was well tolerated by patients enrolled in the trial, said Dr. Belani, lead investigator of the study. These data provide further verification that shortening the duration of radiation treatment may be an important therapeutic strategy for locally advanced NSCLC.

Non-small cell lung cancer is the most common type of lung cancer, accounting for almost 80 percent of lung cancers.

For more information on lung cancer, call UPCIs Cancer Information and Referral Service at 1-800-237-4724, or visit http://www.upci.upmc.edu.

To read more news releases about cancer, please visit the Media Relations Cancer Archives.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com